BDRX: Biodexa Pharmaceuticals plc - American Depositary Shares

BDRX新闻

• 13:43 Biodexa获得大塚制药分子胶化合物用于GIST治疗的独家许可
• 13:40 Biodexa licenses Otsuka’s molecular glue compound for GIST treatment
• 13:56 Biodexa制药任命Fiona Sharp为首席财务官兼董事会成员
• 13:52 Biodexa pharmaceuticals appoints Fiona Sharp as CFO and board member
• 15:50 Biodexa制药公司股价在1000万美元公开募股后下跌
• 15:48 Biodexa Pharmaceuticals stock falls after $10 million public offering
• 13:51 Biodexa定价1000万美元公开发行股票单位和权证
• 13:50 Biodexa定价1000万美元公开发行以资助开发项目
• 13:47 Biodexa prices $10 million public offering of units and warrants
• 13:46 Biodexa prices $10 million public offering to fund development programs
• 05:53 Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)
• 21:30 U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.37%
• 21:30 美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.37%
• 04:48 Why Mama's Creations Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Senmiao Technology (NASDAQ:AIHS), Alexander & Baldwin (NYSE:ALEX)
• 13:42 Biodexa在欧洲招募首批患者参与FAP三期临床试验
• 13:38 Biodexa enrolls first European patients in phase 3 FAP trial
• 13:47 Biodexa在欧洲启动第一个FAP三期临床试验站点
• 13:45 Biodexa activates first European site for phase 3 FAP trial
• 13:41 Biodexa获得EMA批准进行FAP治疗三期临床试验
• 13:37 Biodexa receives EMA approval for phase 3 FAP treatment trial
• 00:49 Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading? - Biodexa Pharmaceuticals (NASDAQ:BDRX)
• 11:13 Biodexa begins phase 3 trial of FAP treatment with $20M funding
• 11:00 Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
• 16:00 Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock?